MedTrace Logo

Stereotactic Non-invasive Ablation of Ventricular Tachycardia

NCT03819504 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-10-19

No results posted yet for this study

Summary

STereotactic Ablative Radiosurgery of recurrent Ventricular Tachycardia in structural heart disease (STAR-VT).

Conditions

  • Ventricular Tachycardia

Interventions

PROCEDURE

4-D navigated stereotactic radio surgical ablation

4-D navigated stereotactic radio surgical ablation will be performed in patients with structural heart disease and sustained monomorphic ventricular tachycardia/tachycardias

Sponsors & Collaborators

  • Institute for Clinical and Experimental Medicine

    collaborator OTHER_GOV

  • Hospital Podlesi

    collaborator OTHER

  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • Jakub Cvek, Ass.Prof.,MD,Ing.,PhD · University Hospital Ostrava

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03819504 on ClinicalTrials.gov